| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 58 |
| 1 | INSULIN ASPART | 16 |
| 2 | LIRAGLUTIDE | 16 |
| 3 | SOMATROPIN | 14 |
| 4 | ABALOPARATIDE | 10 |
| 5 | TERIPARATIDE | 9 |
| 6 | INSULIN LISPRO | 8 |
| 7 | ORAL SEMAGLUTIDE | 7 |
| 8 | EXENATIDE | 5 |
| 9 | ETONOGESTREL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, AND SODIUM BICARBONATE | 1 | 0.0167 |
| 1 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 2 | TECHNETIUM TC-99M | 1 | 0.0016 |
| 3 | INSULIN ASPART INJECTION | 3 | 0.0011 |
| 4 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 5 | FOLLITROPIN ALFA | 2 | 0.0010 |
| 6 | INSULIN GLARGINE AND LIXISENATIDE | 2 | 0.0005 |
| 7 | ESTRIOL | 1 | 0.0005 |
| 8 | HUMAN INSULIN | 3 | 0.0004 |
| 9 | INSULIN GLULISINE | 4 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 83 |
| 1 | GLP-1 Receptor Agonist [EPC] | 30 |
| 2 | Parathyroid Hormone-Related Peptide Analog [EPC] | 10 |
| 3 | Parathyroid Hormone Analog [EPC] | 9 |
| 4 | Recombinant Human Growth Hormone [EPC] | 9 |
| 5 | Progestin [EPC] | 4 |
| 6 | Estrogen [EPC] | 3 |
| 7 | Insulin [EPC] | 3 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 9 | 0.0004 |
| 1 | Parathyroid Hormone-Related Peptide Analog [EPC] | 10 | 0.0003 |
| 2 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 3 | Insulin Analog [EPC] | 83 | 0.0002 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 5 | Progesterone [EPC] | 2 | 0.0001 |
| 6 | Parathyroid Hormone Analog [EPC] | 9 | 0.0001 |
| 7 | GLP-1 Receptor Agonist [EPC] | 30 | 0.0001 |
| 8 | Insulin [EPC] | 3 | 0.0001 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |